Cleared Traditional

K121611 - AMPLATZER TORQVUE FX

K121611 is an FDA 510(k) clearance for AMPLATZER TORQVUE FX, manufactured by Aga Medical Corporation. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 83-day FDA review.

K121611 · Aga Medical Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2012
Decision
83d
Days
Class 2
Risk

K121611 is an FDA 510(k) clearance for the AMPLATZER TORQVUE FX. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Aga Medical Corporation (Plymouth, US). The FDA issued a Cleared decision on August 23, 2012 after a review of 83 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Aga Medical Corporation devices

FDA 510(k) Submission Details - K121611

510(k) Number K121611 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 01, 2012
Decision Date August 23, 2012
Days to Decision 83 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 125d · This submission: 83d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 659
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K121611.
ATTAIN CLARITY 6225 VENOGRAM BALLOON CATHETER
K121219 · Medtronic, Inc. · Sep 2012
TYSHAK NUCLEUS
K121859 · NuMED, Inc. · Aug 2012
RUBICON 18 SUPPORT CATHETER
K122394 · Boston Scientific Corp · Aug 2012
ARMADA 14XXT PTA CATHETER
K121352 · Abbott Vascular · Aug 2012
UNBALLOON NON-OCCLUSIVE MODELING CATHETER
K121839 · LeMaitre Vascular, Inc. · Aug 2012
CONCIERGE GUIDING CATHETER
K121051 · Merit Medical Systems, Inc. · Jun 2012